Young Li
Stock Analyst at Jefferies
(0.77)
# 3,211
Out of 4,667 analysts
5
Total ratings
50%
Success rate
-3.46%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Initiates: Buy | $72 | $44.81 | +60.68% | 1 | Oct 29, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $99.08 | +16.07% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $0.90 | +38.89% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $44.78 | +33.99% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $17.18 | +167.75% | 1 | Jul 16, 2021 |
RxSight
Oct 29, 2024
Initiates: Buy
Price Target: $72
Current: $44.81
Upside: +60.68%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $99.08
Upside: +16.07%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $0.90
Upside: +38.89%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $44.78
Upside: +33.99%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $17.18
Upside: +167.75%